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Abstract
Background: A calcified amorphous tumor of the heart is an extremely rare cardiac mass.
Case presentation: A 32-year-old Albanian man presented to our hospital with fatigue, shortness of breath,
progressive dyspnea, and right congestive heart failure. Echocardiography and chest computed tomography
revealed a giant, calcified right ventricular mass that originated between the papillary muscles and the trabeculae and
extended to the pulmonary valve. The patient underwent surgery with excision of the mass, replacement of the
pulmonary valve with a biological one, and repair of the tricuspid valve. His histopathological examination revealed
that the mass was a calcified, amorphous tumor. His postoperative course was uneventful.
Conclusions: The clinical presentation of the calcified amorphous tumor is similar to that of other cardiac tumors, so
surgical excision is mandatory. Histopathological examination remains the gold standard for an accurate diagnosis.
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Background
A calcified amorphous tumor of the heart (CAT) is a
rare, nonneoplastic cardiac tumor or intracavitary cardiac
mass composed of calcium deposits in a background of
amorphous, degenerating, fibrinous material. This cardiac
tumor may be confused with primary cardiac neoplasms
such as a calcified cardiac myxoma or calcified thrombi.
Only a few cases of this rare lesion have been reported in
the literature [1–4]. Histopathological examination is the
most exact method for making the diagnosis.
Case presentation
A 32-year-old Albanian man presented to our hospital
with fatigue, cough, shortness of breath and progressive
dyspnea, liver distention, and edema in the lower extrem-
ities, suggestive of right congestive heart failure. He was
first treated for tracheobronchitis. Contrast-enhanced
chest computed tomography (CT) was performed, which
revealed a large, calcified right ventricular mass measuring
4 × 10 cm (Fig. 1a), a dilated pulmonary trunk approxi-
mately 4 cm in diameter, and thrombosis at the origin of
the right pulmonary artery. The pulmonary trunk and left
pulmonary branch were visualized with uniform contrast
enhancement (Fig. 1b).
The patient had a family history of antithrombin III
(AT3) deficiency. He had mild AT3 deficiency at 60 U/ml
(normal AT3 value is 80 U/ml). His two sisters had pul-
monary thromboembolisms and were being treated with
major anticoagulants. The patient’s parathyroid hormone,
phosphorus, and serum calcium concentrations were nor-
mal. The results of his routine laboratory examinations
were within normal limits, except for a high level of
bilirubin due to biliary stasis. He had no thrombosis of
the venous circulation in his legs.
Transthoracic echocardiography (TTE) (Fig. 1c) and
transesophageal echocardiography (TEE) (Fig. 1d) were* Correspondence: ninakajo@yahoo.com
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performed. The imaging studies showed a 4 × 7–cm
right ventricular mass that was hyperechogenic and cal-
cified, and it appeared to be broad-based in the papillary
muscles and trabeculae of the right ventricle with exten-
sion into the infundibulum and pulmonary valve. Slight
tricuspid annular calcification was also recognized. The
mass moved with ventricular wall contraction; no prolapse
through the tricuspid valve into the right atrium was ob-
served; and the septal tricuspid valve was hyperechogenic.
The right atrium and right ventricle were dilated with
volume and pressure overload. The patient’s pulmonary
pressure was high, up to 70 mmHg.
After cardiac CT and TEE were performed, the patient
underwent surgical resection of the mass with a clinical
diagnosis of calcified thrombi or any other cardiac neo-
plasms. Surgical intervention on 2 December 2014 con-
sisted of right ventriculotomy, which revealed a giant
calcified mass from the apex to the medial pulmonary
artery (Fig. 2a and b). The pulmonary valve was damaged
due to the CAT and was practically nonexistent. Substitu-
tion of the pulmonary valve with a Freestyle stentless
bioprosthesis (number 25; Medtronic, Minneapolis, MN,
USA), repair of the tricuspid valve (cleft suture), and ex-
tensive endarterectomy of right pulmonary branch were
performed. The specimen was sent for histopathological
examination.
Macroscopically, the material extracted from the right
ventricle was of a conglomerated, reddish-brown, dry, clot-
like consistency with a tendency to crumble when cut, and
it was calcified and had high consistency (Fig. 2a and b). Fo-
cally mineralized calcification was present in the center of
the tumor. Decalcification was performed before the tumor
was processed for histological examination. Microscopic-
ally, the sections showed a lesion composed of a back-
ground of eosinophilic, amorphous material, possibly
degenerated fibrin, with areas of dense calcification and
focal chronic inflammation and aggregates of spumoseus
histiocytes (Fig. 2c and d). The material of the pulmonary
artery had a fibrinoid aspect and calcium nodes. No mitoses
or malignant elements were seen.
Considering the clinical and histological features, a
diagnosis of CAT was made. The patient’s postoperative
period was uneventful. Postoperative TEE was performed
(Fig. 3a and b). No cardiac mass was seen; the function of
the pulmonary prosthesis was normal; the patient’s max-
imal gradient was 25 mmHg; no pulmonary regurgitation
was present; the infundibulum was free of mass; no vol-
ume or pressure overload of the right ventricle was
present; mild tricuspid regurgitation was present; and
the patient’s pulmonary pressure was 35 mmHg.
Postoperative contrast-enhanced chest CT showed no
cardiac mass (Fig. 3c). The image provided good contrast
Fig. 1 a Chest computed tomographic scan demonstrates an approximately 4 × 10–cm calcified mass in the right ventricle attached to the
pulmonary valve. b Thrombosis of the origin of the right pulmonary artery is visualized with uniform contrast enhancement of the pulmonary
trunk and the left pulmonary artery. c Transthoracic echocardiographic study and d transesophageal echocardiographic scan reveal a calcified
mass in the right ventricle attached to the pulmonary valve
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Fig. 3 a and b Postoperative transesophageal echocardiography demonstrates no cardiac mass, the biologic prosthesis in pulmonary position,
free tricuspid valve, and dilation of the right ventricle. c Postoperative chest computed tomography demonstrates good contrast visualization of
the trunk and the two branches of the pulmonary artery
Fig. 2 a Material remnants of the calcified mass removed from the right ventricle with surgical intervention. The remnants were conglomerated
and had high consistency. b On the right side, the material of the pulmonary artery with a fibrinoid aspect and calcium nodes is seen. c Histopathological
examination revealed a homogeneous, eosinophilic, largely acellular lesion with extensive areas of dystrophic calcification (hematoxylin and eosin stain,
original magnification ×10). d The amorphous, fibrin-like material and hyaline formation in some areas is mixed with extravasated erythrocytes, spumous
cells, and mild inflammatory cells
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visualization of the free right branch of the pulmonary ar-
tery that had been occluded before surgery. The patient
was successfully treated and discharged from the hospital.
Two months after his operation, the patient was healthy.
He has to be followed with echocardiography for any
possible future recurrence.
Discussion
Primary cardiac tumors are rare, and the great majority
of them are benign neoplasms [2]. The most common
benign cardiac tumors are myxomas, accounting for 50
% of all benign cardiac tumors; however, not all cardiac
masses are neoplasms. For instance, intramural thrombi
are great mimics of neoplasms [3, 5]. Regardless of the
nature of a cardiac mass (neoplastic or not), excision of
the lesion is important due to the potential danger of
obstruction or embolization [5–8].
CAT is a rare entity that was first described by Reynolds
et al. in 1997 [3]. A review of the literature of 16 previ-
ously reported cases is also included [1, 3]. The rarity of
this lesion is borne out by the fact that a 29-year review
done at the Mayo Clinic yielded only 11 such cases [3].
On the basis of the findings in the Mayo Clinic series,
CAT can originate in any cardiac chamber, tumor size and
configuration are variable, and most of the tumors are
located in intracavitary spaces and are motionless. They
are described as nonneoplastic intracardiac lesions com-
posed of nodules of calcium on a background of amorph-
ous, fibrinous material with degeneration and focal
chronic inflammation [3, 8].
Histologically, CAT consists of calcification and eosino-
philic amorphous material in a background of dense, col-
lagenous, fibrous tissue [2]. The mean age at the time of
diagnosis is about 52 years (with an age range from 16 to
75 years) [1, 2, 9]. There is a slight female predominance;
however, our patient was a 32-year-old man.
The clinical presentation of CAT is similar to that of
other cardiac masses (that is, dyspnea, syncope, or symp-
toms related to embolism). Differential clinical diagnoses
include cardiac calcified myxoma or fibroma, calcified
cardiac tuberculoma, thrombi, emboli, vegetations, and
intracardiac carcinosis, especially in patients with hemo-
dialyzed end-stage renal disease and abnormal calcium
and phosphorus metabolism; other benign and malignant
cardiac tumors may be included as well [10–12].
TTE, TEE, and other examinations help identify the
location, echogenicity, and morphology of cardiac masses.
CATs are described as pedunculated, diffusely calcified
masses visualized on echocardiograms [13–15]. They can
grow in any cardiac chamber and on the mitral valve
as well, but they are predominantly found on the left
ventricle. In our patient, the CAT was found on the right
ventricle, chordae tendineae, papillary muscles, and the
infundibulum, reaching the pulmonary valve. These
masses can reach a size of up to 9 cm in the greatest di-
mension; our patient’s tumor measured 7 cm.
In the absence of distinctive clinical and imaging fea-
tures, a preoperative differentiation between neoplastic
and nonneoplastic lesions remains difficult. Surgical re-
section of CATs is prompted by clinical suspicion of
malignancy or due to obstructive or embolic complica-
tions [2, 4, 6, 13, 15]. Our patient presented with a right
branch pulmonary embolism.
Hence, histological diagnosis is the gold standard for a
definitive diagnosis [2, 4, 9, 16]. In our patient, extensive
sampling failed to reveal any myxomatous tissue charac-
teristic of myxomas. Thrombi may undergo mummifica-
tion and calcification and mimic CAT. The absence of
predisposing conditions for thrombosis and infrequent
presence of hemosiderin differentiate CAT from an or-
ganizing thrombus [3, 17]. Although the pathogenesis of
CAT is uncertain, association with organized thrombi, pri-
mary or secondary hypercoagulability [16], or abnormal
calcium and phosphorus metabolism, especially in hemo-
dialyzed patients [10–12], has been suggested.
Surgical excision is mandatory for diagnosis and treat-
ment [2, 4, 6]. The majority of patients reported have had
a benign course after surgical excision. Sometimes, some
residual calcium may be seen [3]. Postoperative recurrence
of CAT has rarely been reported [1, 16, 18]. TEE can re-
veal residual tumor. Regular postoperative follow-up with
cardiac imaging studies is recommended, especially in
cases of incomplete resection [9, 14, 16, 17].
Conclusions
CAT is a rare intracardiac nonneoplastic mass. Its clinical
presentation is similar to that of other cardiac tumors, so
surgical excision is mandatory. Histopathological examin-
ation remains the gold standard for an accurate diagnosis.
Regular postoperative follow-up with cardiac imaging
studies is recommended to detect any possible recurrence.
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